Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Domitor Inj 1mg/mL 1 mg Solution is a Health Canada–registered veterinary drug (DIN 01950673) held by Orion Corporation, containing Medetomidine Hydrochloride. Health Canada lists its status as Dormant (status date 26 Jun 2019). Nexara Health has matched 4 registrations of Medetomidine Hydrochloride across 2 other regulated markets.

Health Canada registration

DIN01950673
Brand nameDomitor Inj 1mg/mL
Active ingredientMedetomidine Hydrochloride
Strength1 mg
Dosage formSolution
RouteIntramuscular ; Intravenous
CompanyOrion Corporation
StatusDormant — 26 Jun 2019
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Medetomidine Hydrochloride registered in other markets

4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
PolandCepetor 1 mg/ml roztwór do wstrzykiwań dla psów i kotówCP-Pharma Handelsgesellschaft mbH1 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
PolandDomitor 1 mg/1 ml, roztwór do wstrzykiwań dla psów i kotówOrion Corporation1 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
United StatesMedetomidinePharmatory OyPowderFDA NDC
United StatesMedetomidine HydrochlorideInterquim, S.A. de C.V.PowderFDA NDC

See every manufacturer of Medetomidine Hydrochloride worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Domitor Inj 1mg/mL (DIN 01950673) marketed in Canada?

No. Health Canada lists DIN 01950673 as Dormant as of 26 Jun 2019.

Who holds the Canadian licence for this product?

Orion Corporation is the company of record in the Health Canada Drug Product Database.

Is Medetomidine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01950673, status date 2019-06-26; national medicine registries: FDA NDC, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01950673, status date 2019-06-26; national medicine registries: FDA NDC, URPL RPL.

Health Canada Drug Product Database (DPD), DIN 01950673, status date 2019-06-26; national medicine registries: FDA NDC, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.